PGX-processed yeast beta-glucans as an inhalable immunomodulating therapeutic for COVID-19 patients

While many people who acquire COVID-19 experience only minor symptoms or are completely asymptomatic, others (~20% of patients) experience a severe form of the disease associated with a phenomenon called a cytokine storm, an undesirable immune response that ultimately results in the deposition of fibrotic tissue in the lungs that causes the breathing difficulties and […]

Read More